DURECT Corporation filed its 10-K on Mar 08, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -4.65% | +28.12% | +108.47% |
May. 21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
May. 21 | Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.47% | 38.17M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.08% | 21.97B | |
-5.24% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- DURECT Corporation Auditor Raises 'Going Concern' Doubt